Retinoic acid-induced protein 1 (RAI1)

Retinoic acid-induced protein 1 (RAI1) is a nuclear transcriptional regulator that is highly expressed in neurons, mediating gene expression involved in neurodevelopment, cognitive and motor skills, circadian rhythm, and metabolic homeostasis[1][2][4][5][7]. Located on chromosome 17p11.2, RAI1 contains polyglutamine tracts, bipartite nuclear localization signals, and a plant homeodomain zinc finger motif corresponding to histone "reader" proteins[4][1]. Mutations or deletions of RAI1 result in Smith-Magenis syndrome, a disorder characterized by intellectual disability, distinctive behavior, obesity, craniofacial anomalies, and disrupted sleep-wake cycles[2][4][5][6][7]. Gene duplication leads to Potocki-Lupski syndrome, which features developmental delay, autistic traits, and sleep disturbances[7][8]. RAI1 influences the transcriptional regulation of important neuronal genes (e.g., BDNF) and is crucial for normal brain, skeletal, and metabolic development[1][3][4][9]. The protein is not currently a therapeutic drug target; it is instead studied in disease genetics and neurodevelopmental research.

Other names

KIAA1820DKFZP434A139SMSMGC12824SMCRSmith-Magenis syndrome chromosome region protein